Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Item

http://www.wikidata.org/entity/Q34647260

Q34647260

about

Variation in LPA is associated with Lp(a) levels in three populations from the Third National Health and Nutrition Examination Survey Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis Statins in cardiometabolic disease: what makes pitavastatin different?The prevention and regression of atherosclerotic plaques: emerging treatments.Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study β-COP as a Component of Transport Vesicles for HDL Apolipoprotein-Mediated Cholesterol Exocytosis Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation.The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study.Overweight and obesity among low-income Muslim Uyghur women in far western China: correlations of body mass index with blood lipids and implications in preventive public health Association of scavenger receptor class B type I polymorphisms with subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis Common carotid artery wall thickness and external diameter as predictors of prevalent and incident cardiac events in a large population study.Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease.Reversal of small, dense LDL subclass phenotype by normalization of adiposity.High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease.Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence.Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans.Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial.Diet and serum lipids: changes over socio-economic transition period in Lithuanian rural population.Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Genetic causes of high and low serum HDL-cholesterol.Dietary squalene increases high density lipoprotein-cholesterol and paraoxonase 1 and decreases oxidative stress in mice Plasma folate levels are associated with the lipoprotein profile: a retrospective database analysis.Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study.Comparison of various formulae for estimating low-density lipoprotein cholesterol by a combination of ages and genders in Taiwanese adults.Atherogenic dyslipidemia: cardiovascular risk and dietary intervention Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease The characteristics of dyslipidemia patients with different durations in Beijing: a cross-sectional study.The association between fasting serum insulin, apo-lipoproteins level, and severity of coronary artery involvement in non-diabetic patients

P2860

Q21135561-9EE7D155-3574-401A-9C0A-B4307DD428A2 Q24626884-7FDADA45-1AF8-48E5-B5F5-BD2AC651601E Q26745946-5685B18A-2593-4DC4-9913-B69118E4A6B1 Q27000723-25BA58A3-69C8-465B-B4E2-B6F55672EA58 Q27000959-72546A05-1557-43B4-B7BB-C1785ED1FA59 Q27010638-68D41EDA-7C53-427D-98E0-49A7E9B89278 Q27691367-2D579708-46A4-497A-83E1-BCC1044F7AFC Q28219423-09536799-0F5A-467C-8B2A-D3045FFF4371 Q28244205-94C3EA7A-7741-42FE-B865-36E8E4C0F0F9 Q28254321-3B61ADCD-4A7C-4C26-87D6-D8BCA3535AC3 Q28550835-5793BED4-6EE3-484E-A4D3-8DD22537AB33 Q30242031-BA7D3B91-187D-4CB7-B7F5-87417E280905 Q30251918-9D03A447-4759-41B2-A8A8-4676E656CF97 Q30278617-BA0878C0-DEC3-4395-A4E0-3FB6B20A0FE5 Q30359702-123BE6BC-222F-4C24-BC7C-A56844B1350C Q30426824-4CA650EC-40F9-4249-A5D3-ED5CB85E69E7 Q30499427-BD43C7F7-F00F-4EE2-AB91-C829FB4A2AD6 Q33537687-142846C8-91D6-4998-A338-774F6495DD22 Q33590777-6CB7A664-705F-47F9-8D3A-37C71B669B3F Q33680333-DE174735-A746-40DF-9C56-40228F37BC0D Q33721993-686AA309-CD9F-4C6A-9F11-75E4FE8F292E Q33737098-7544F03F-BDBC-4C60-8374-6D57288C246F Q33739176-22822282-BBF8-4281-ACBE-BD64118BF9E8 Q33808934-BC686E3B-B8D9-4DED-B043-FE09BD473F24 Q33863769-5F0CB971-6F82-4DA6-81C6-DE7CF78E2FD8 Q33877463-C98EE1A8-EFB2-4399-8C76-B733BCD08177 Q33926028-557EC052-7EF4-4EA4-A66D-1E46E67A04CC Q33932598-2A6A2FA1-7795-4D88-A131-86AB70B98D7D Q33972551-E4ED8F4E-0569-4B0D-8BE6-16A4E57E0E24 Q33993060-E7274F91-A8E6-45D9-81AE-CDF9CDCC4329 Q34035387-72CD5448-02C0-44E4-94F0-82D003168B1A Q34047459-1A3D8D6C-3D1D-4BBA-A8F7-8E5A65FF1A40 Q34102781-AB3753BE-6C19-42FC-BF39-CB482431A74E Q34149298-38F63CE5-CF4E-40FC-AB60-31062178FC4B Q34169130-F8AC37E5-C026-454A-9E41-D12DD330538E Q34180234-C327D21C-FE0C-4F66-8D08-03573D04F59D Q34222469-A1913CB2-48FC-49AB-A7A0-9CC4632A087C Q34238727-548DC028-1972-4D8A-ADC8-32BDC46C242F Q34244128-045C3E32-80D6-4C25-94F6-45C7F66649A6 Q34304335-58A0DE1D-1714-4236-8F85-2264C0C19FDA

P2860

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Item

http://www.wikidata.org/entity/Q34647260

description

2001 nî lūn-bûn

@nan

2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue